» Articles » PMID: 9109916

Cognitive Function and Academic Performance in Neurofibromatosis. 1: Consensus Statement from the NF1 Cognitive Disorders Task Force

Overview
Journal Neurology
Specialty Neurology
Date 1997 Apr 1
PMID 9109916
Citations 65
Authors
Affiliations
Soon will be listed here.
Citing Articles

Neurocognitive functioning in adults with neurofibromatosis type 1- a nationwide population-based study.

Doser K, Jepsen J, Kenborg L, Miskowiak K, Albieri V, Dalton S Orphanet J Rare Dis. 2024; 19(1):441.

PMID: 39609892 PMC: 11603635. DOI: 10.1186/s13023-024-03454-w.


Visual Deficits and Diagnostic and Therapeutic Strategies for Neurofibromatosis Type 1: Bridging Science and Patient-Centered Care.

Miyagishima K, Qiao F, Stasheff S, Nadal-Nicolas F Vision (Basel). 2024; 8(2).

PMID: 38804352 PMC: 11130890. DOI: 10.3390/vision8020031.


Statins in Children with Neurofibromatosis Type 1: A Systematic Review of Randomized Controlled Trials.

Agouridis A, Palli N, Karagiorga V, Konsoula A, Markaki L, Spernovasilis N Children (Basel). 2023; 10(9).

PMID: 37761518 PMC: 10528298. DOI: 10.3390/children10091556.


Polysomnographic study in pediatric neurofibromatosis type 1.

Carotenuto M, Messina G, Esposito M, Santoro C, Iacono D, Spruyt K Front Neurol. 2023; 14:1213430.

PMID: 37538252 PMC: 10394094. DOI: 10.3389/fneur.2023.1213430.


Evaluating Focal Areas of Signal Intensity (FASI) in Children with Neurofibromatosis Type-1 (NF1) Treated with Selumetinib on Pediatric Brain Tumor Consortium (PBTC)-029B.

Pillay-Smiley N, Leach J, Lane A, Hummel T, Fangusaro J, de Blank P Cancers (Basel). 2023; 15(7).

PMID: 37046770 PMC: 10092996. DOI: 10.3390/cancers15072109.